why isnt bpc 157 fda approved BPC-157 Just Cleared a Major Regulatory Hurdle If you've been following the peptide world, you've probably heard the buzz about BPC-157. Here's what actually happened: ✓ An advisory committee voted to Big news for the peptide

Whilst vitamin B12 toxicity is exceptionally rare due to its water-soluble nature, very high levelsparticularly from mega-dose supplements or frequent injectionshave been associated with certain adverse effects, most notably skin reactions

Important notes: GH peptides require fasted administration for optimal effect

Additional at-risk groups include: Vegans and strict vegetarians , who may have low dietary B12 intake People with autoimmune conditions , including pernicious anaemia or type 1 diabetes Individuals with gastrointestinal conditions such as Crohn's disease or coeliac disease, which impair nutrient absorption People who have undergone bariatric surgery , which can significantly reduce B12 absorption Long-term users of proton pump inhibitors (PPIs) or H2-receptor antagonists , which reduce gastric acid and impair B12 release from food Those with a family history of either pernicious anaemia or diabetes For these groups, simultaneous monitoring of B12 status and glycaemic markers is particularly important to avoid diagnostic errors

Ilic S, Brcic I, Mester M, Filipovic M, Sever M, Klicek R, et al